ZYBT
NASDAQ · Pharmaceuticals
Zhengye Biotechnology Holdin
$0.83
-0.04 (-4.43%)
Open$0.84
Previous Close$0.87
Day High$0.88
Day Low$0.79
52W High$14.30
52W Low$0.68
Volume—
Avg Volume55.0K
Market Cap33.43M
P/E Ratio—
EPS$-0.21
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 142.12M | 12.11M | 10.68M |
| Net Income | 8.63M | 2.69M | 1.92M |
| Profit Margin | 6.1% | 22.3% | 18.0% |
| EBITDA | 31.79M | 3.66M | 3.67M |
| Free Cash Flow | — | 1.61M | 1.47M |
| Rev Growth | +854.8% | -0.1% | -5.4% |
| Debt/Equity | 0.30 | 0.37 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |